Invasive and non-invasive diagnosis of cirrhosis and portal hypertension

Moonyoung Kim, Woo Kyoung Jeong, Soonkoo Baik

Research output: Contribution to journalReview article

52 Citations (Scopus)

Abstract

With advances in the management and treatment of advanced liver disease, including the use of antiviral therapy, a simple, one stage description for advanced fibrotic liver disease has become inadequate. Although refining the diagnosis of cirrhosis to reflect disease heterogeneity is essential, current diagnostic tests have not kept pace with the progression of this new paradigm. Liver biopsy and hepatic venous pressure gradient measurement are the gold standards for the estimation of hepatic fibrosis and portal hypertension (PHT), respectively, and they have diagnostic and prognostic value. However, they are invasive and, as such, cannot be used repeatedly in clinical practice. The ideal noninvasive test should be safe, easy to perform, inexpensive, reproducible as well as to give numerical and accurate results in real time. It should be predictive of long term outcomes related with fibrosis and PHT to allow prognostic stratification. Recently, many types of noninvasive alternative tests have been developed and are under investigation. In particular, imaging and ultrasound based tests, such as transient elastography, have shown promising results. Although most of these noninvasive tests effectively identify severe fibrosis and PHT, the methods available for diagnosing moderate disease status are still insufficient, and further investigation is essential to predict outcomes and individualize therapy in this field.

Original languageEnglish
Pages (from-to)4300-4315
Number of pages16
JournalWorld Journal of Gastroenterology
Volume20
Issue number15
DOIs
Publication statusPublished - 2014 Apr 21

Fingerprint

Portal Hypertension
Fibrosis
Liver Diseases
Liver
Elasticity Imaging Techniques
Venous Pressure
Routine Diagnostic Tests
Antiviral Agents
Ultrasonography
Biopsy
Therapeutics

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

@article{026864dde8db4d9aa62e66e4fbdb6203,
title = "Invasive and non-invasive diagnosis of cirrhosis and portal hypertension",
abstract = "With advances in the management and treatment of advanced liver disease, including the use of antiviral therapy, a simple, one stage description for advanced fibrotic liver disease has become inadequate. Although refining the diagnosis of cirrhosis to reflect disease heterogeneity is essential, current diagnostic tests have not kept pace with the progression of this new paradigm. Liver biopsy and hepatic venous pressure gradient measurement are the gold standards for the estimation of hepatic fibrosis and portal hypertension (PHT), respectively, and they have diagnostic and prognostic value. However, they are invasive and, as such, cannot be used repeatedly in clinical practice. The ideal noninvasive test should be safe, easy to perform, inexpensive, reproducible as well as to give numerical and accurate results in real time. It should be predictive of long term outcomes related with fibrosis and PHT to allow prognostic stratification. Recently, many types of noninvasive alternative tests have been developed and are under investigation. In particular, imaging and ultrasound based tests, such as transient elastography, have shown promising results. Although most of these noninvasive tests effectively identify severe fibrosis and PHT, the methods available for diagnosing moderate disease status are still insufficient, and further investigation is essential to predict outcomes and individualize therapy in this field.",
author = "Moonyoung Kim and Jeong, {Woo Kyoung} and Soonkoo Baik",
year = "2014",
month = "4",
day = "21",
doi = "10.3748/wjg.v20.i15.4300",
language = "English",
volume = "20",
pages = "4300--4315",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "15",

}

Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. / Kim, Moonyoung; Jeong, Woo Kyoung; Baik, Soonkoo.

In: World Journal of Gastroenterology, Vol. 20, No. 15, 21.04.2014, p. 4300-4315.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Invasive and non-invasive diagnosis of cirrhosis and portal hypertension

AU - Kim, Moonyoung

AU - Jeong, Woo Kyoung

AU - Baik, Soonkoo

PY - 2014/4/21

Y1 - 2014/4/21

N2 - With advances in the management and treatment of advanced liver disease, including the use of antiviral therapy, a simple, one stage description for advanced fibrotic liver disease has become inadequate. Although refining the diagnosis of cirrhosis to reflect disease heterogeneity is essential, current diagnostic tests have not kept pace with the progression of this new paradigm. Liver biopsy and hepatic venous pressure gradient measurement are the gold standards for the estimation of hepatic fibrosis and portal hypertension (PHT), respectively, and they have diagnostic and prognostic value. However, they are invasive and, as such, cannot be used repeatedly in clinical practice. The ideal noninvasive test should be safe, easy to perform, inexpensive, reproducible as well as to give numerical and accurate results in real time. It should be predictive of long term outcomes related with fibrosis and PHT to allow prognostic stratification. Recently, many types of noninvasive alternative tests have been developed and are under investigation. In particular, imaging and ultrasound based tests, such as transient elastography, have shown promising results. Although most of these noninvasive tests effectively identify severe fibrosis and PHT, the methods available for diagnosing moderate disease status are still insufficient, and further investigation is essential to predict outcomes and individualize therapy in this field.

AB - With advances in the management and treatment of advanced liver disease, including the use of antiviral therapy, a simple, one stage description for advanced fibrotic liver disease has become inadequate. Although refining the diagnosis of cirrhosis to reflect disease heterogeneity is essential, current diagnostic tests have not kept pace with the progression of this new paradigm. Liver biopsy and hepatic venous pressure gradient measurement are the gold standards for the estimation of hepatic fibrosis and portal hypertension (PHT), respectively, and they have diagnostic and prognostic value. However, they are invasive and, as such, cannot be used repeatedly in clinical practice. The ideal noninvasive test should be safe, easy to perform, inexpensive, reproducible as well as to give numerical and accurate results in real time. It should be predictive of long term outcomes related with fibrosis and PHT to allow prognostic stratification. Recently, many types of noninvasive alternative tests have been developed and are under investigation. In particular, imaging and ultrasound based tests, such as transient elastography, have shown promising results. Although most of these noninvasive tests effectively identify severe fibrosis and PHT, the methods available for diagnosing moderate disease status are still insufficient, and further investigation is essential to predict outcomes and individualize therapy in this field.

UR - http://www.scopus.com/inward/record.url?scp=84898864219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898864219&partnerID=8YFLogxK

U2 - 10.3748/wjg.v20.i15.4300

DO - 10.3748/wjg.v20.i15.4300

M3 - Review article

VL - 20

SP - 4300

EP - 4315

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 15

ER -